Correlation Between Hillstream Biopharma and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Hillstream Biopharma and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and LMF Acquisition.
Diversification Opportunities for Hillstream Biopharma and LMF Acquisition
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hillstream and LMF is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and LMF Acquisition go up and down completely randomly.
Pair Corralation between Hillstream Biopharma and LMF Acquisition
Given the investment horizon of 90 days Hillstream Biopharma is expected to generate 0.44 times more return on investment than LMF Acquisition. However, Hillstream Biopharma is 2.27 times less risky than LMF Acquisition. It trades about -0.01 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about -0.02 per unit of risk. If you would invest 43.00 in Hillstream Biopharma on August 29, 2024 and sell it today you would lose (4.00) from holding Hillstream Biopharma or give up 9.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 13.49% |
| Values | Daily Returns |
Hillstream Biopharma vs. LMF Acquisition Opportunities
Performance |
| Timeline |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| LMF Acquisition Oppo |
Hillstream Biopharma and LMF Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hillstream Biopharma and LMF Acquisition
The main advantage of trading using opposite Hillstream Biopharma and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
| LMF Acquisition vs. ZyVersa Therapeutics | LMF Acquisition vs. Sonnet Biotherapeutics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |